Drug
Baxdrostat
Baxdrostat: highest development phase Phase 3, developed by AstraZeneca. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- AstraZeneca
Trials
| Drug | Phase | Indication |
|---|---|---|
| Baxdrostat NCT06034743 | Phase 3 | Uncontrolled Hypertension |
| baxdrostat 2mg NCT07686120 | Phase 3 | Uncontrolled Hypertension |
Latest
No recent events.
Follow Baxdrostat on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.